US patient monitoring market worth $3.1B in 2011

By Brian Dolan
Share

Withings Blood PressureAccording to a new report from iData Research, the US patient monitoring market was worth more than $3.1 billion in 2011 and it is expected to approach $4.2 billion by 2018. The research firm points to a few key drivers of this growth: the rapid adoption of wireless ambulatory telemetry monitors, low acuity vital signs monitors, telehealth services for chronic condition management, and monitoring of cardiovascular implantable electronic devices. The firm also expects traditional monitoring products like multi-parameter vital signs monitoring, telemetry, fetal and neonatal monitoring, to continue to grow as they replace outdated systems.

The report comes just a few days after a similar report from GBI hit the wires: Earlier this week GBI predicted that the global patient monitoring devices market will hit $8 billion in 2017, up from $6.1 billion in 2010. The firm estimated the device market’s CAGR at about 4 percent for the next five years. Like iData, GBI pointed to advancements in wireless and sensor technologies as a key driver of the patient monitoring devices market.

iData also reported that physicians and clinicians are becoming more aware of remote monitoring of patients after discharge from the hospital. The firm also said that smartphone compatible monitoring products will drive sales for some corners of the market, including pulse oximetry and blood pressure monitoring. The benefits of a smartphone compatible monitoring device are: "convenience of monitoring, ease of use, familiar platform for smartphone users, new and exciting method for measuring blood pressure, and the ability to share and analyze results," according to iData.

"The growing awareness of the benefits of remote monitoring, in addition to large purchases by the Department of Veterans Affairs has helped drive growth in the telehealth for the chronic conditions segment," Dr. Kamran Zamanian, CEO of iData stated in a release. "By 2018, the US telehealth market is expected to more than double in value, with companies such as Honeywell, Bosch Healthcare and Cardiocom battling for market share."

More in the release below:

PRESS RELEASE: Vancouver, BC (PRWEB) March 27, 2012 -- According to a new report by iData Research (www.idataresearch.net), the leading global authority in medical device market research, the U.S. patient monitoring market was valued at over $3.1 billion in 2011 and will grow to almost $4.2 billion by 2018 due to rapid adoption of wireless ambulatory telemetry monitors, and low-acuity vital signs monitors as well as telehealth for both remote monitoring of chronic conditions and for patients with CIEDs. Traditional monitoring products including multi-parameter vital signs monitoring, telemetry, fetal and neonatal monitoring will continue to grow to replace outdated systems.

"The growing awareness of the benefits of remote monitoring, in addition to large purchases by the Department of Veterans Affairs has helped drive growth in the telehealth for the chronic conditions segment," says Dr. Kamran Zamanian, CEO of iData. "By 2018, the U.S. telehealth market is expected to more than double in value, with companies such as Honeywell, Bosch Healthcare and Cardiocom battling for market share."

The report states that the wireless ambulatory telemetry monitor market rapidly expanded in 2011. Physicians and clinicians are becoming more aware of the benefits provided by patient mobility after surgery, in particular, faster recovery and a quicker hospital discharge. Patient-worn monitor unit sales are expected to increase dramatically over the forecast period as telemetry monitoring expands to general ward areas.

In addition, emerging smartphone compatible monitoring products are entering the market, which are expected to drive sales, particularly for the pulse oximetry and blood pressure monitoring segments.

"Several pulse oximetry and blood pressure monitoring products which connect to smartphone devices were announced in the U.S. market," says Dr. Zamanian. "Factors which will drive the uptake of smartphone compatible monitors include convenience of monitoring, ease of use, familiar platform for smartphone users, new and exciting method for measuring blood pressure, and the ability to share and analyze results."

For more information, register free on iData's website at:

www.idataresearch.net/idata/registration.php

iData's 3-report series on the: "Markets for Patient Monitoring Equipment & Devices 2012" includes the U.S., Europe (15 countries) and Asia-Pacific (3 countries) and covers multi-parameter vital sign monitors; wireless ambulatory telemetry monitoring; telehealth; intra-cranial pressure monitors and consumables; electromyogram devices and consumables; electroencephalogram monitors; cerebral oximetry monitors and consumables; fetal and neonatal monitors; pulse oximetry monitors, consumables and circuit boards; cardiac output devices and consumables; and blood pressure monitors.

About iData Research

iData Research (www.idataresearch.net/idata/discoveridata.php) is an international market research and consulting group focused on providing market intelligence for medical device, dental and pharmaceutical companies. iData covers research in: patient monitoring, endoscopy, women's health, cardiovascular, orthopedics and more.

nike air max 2019 dress